Cargando…
The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer
National and international consortia will play a key role in understanding the effects of the coronavirus disease 2019 (COVID-19) pandemic on cancer patients. The COVID-19 and Cancer Consortium (CCC19) aims to collect and analyze observational data at scale to inform clinical practice in real-time.
Autores principales: | Rubinstein, Samuel M., Steinharter, John A., Warner, Jeremy, Rini, Brian I., Peters, Solange, Choueiri, Toni K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188629/ https://www.ncbi.nlm.nih.gov/pubmed/32454025 http://dx.doi.org/10.1016/j.ccell.2020.04.018 |
Ejemplares similares
-
COVID-19 and Cancer: Current Challenges and Perspectives
por: Bakouny, Ziad, et al.
Publicado: (2020) -
Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry
por: Li, Ang, et al.
Publicado: (2020) -
LBA72 Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS-CoV-2 infection: The COVID-19 and Cancer Consortium (CCC19)
por: Grivas, P., et al.
Publicado: (2020) -
Care without a compass: Including patients with cancer in COVID-19 studies
por: Friese, Christopher R., et al.
Publicado: (2021) -
Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study
por: Satyanarayana, Gowri, et al.
Publicado: (2022)